Research/Associate Scientist: Cell Delivery & Formulation Cell Therapy
Denne stilling er desværre ikke længere ledig.
Se alle ledige stillinger
Måløv
Do you want to take part in creating the cell therapies of the future? Do you have the knowledge, experience, and ethics required to drive the successful in vitro testing and development of cellular shipping and delivery formulations in combination with their delivery devices? Do you thrive in a fast-paced, ambitious, and multidisciplinary environment? Then apply today and join our efforts to bring safe and effective cell therapies into the clinic and out to improve the lives of people living with serious chronic diseases. The positions
We are expanding our team and are looking for two scientists (2-year positions with the possibility to extent) with expertise relevant to the in vitro testing of formulations and the combination of delivery device, formulation, and cells. These tasks cover a multidisciplinary area of cell biology, formulation characterization, microfluidics, biomaterial characterization and in vitro assay development. You will support the progression of our Parkinson’s Disease and Chronic Heart Failure cell therapy programs in Cell Therapy R&D. Your main tasks will include:
• Supporting the team with hands on experiments and in-depth knowledge contributing to the development and maturation of cell formulations enabling the progression of our Parkinson’s Disease and Heart Failure cell therapy programs towards global clinical adoption.
• Being part of our internal and external project teams and responsible for in vitro study designs and execution, assay read-outs, interpretation of results, and communicating and discussing conclusions with a broad spectrum of stakeholders and collaborators across our organization. Qualifications
The position requires curiosity, adaptability, and a creative mindset together with good time and resource management skills. You need to thrive in an environment where we work in collaborative teams and rely on each other; e.g., for technical, strategic, regulatory, and clinical expertise - making communication is an essential skill. To succeed in this role, you have:
• M.Sc. or Ph.D. in engineering, pharmaceutical, biological, biomedical sciences, or a related field. Experience and understanding of in vitro study design,
• hands on-experience in assay development, cell biology and/or biomedical engineering is advantageous.
• Prior knowledge about GLP, GMP, and regulatory frameworks are an advantage but not a prerequisite. About the department
The Department of Cell Delivery & Formulation is a dynamic and diverse department in Cell Therapy R&D, a Transformational Research Unit (TRU) within Novo Nordisk. The TRU is unique in the sense that it covers the full R&D value chain, which means we function as an integrated unit, spanning from early research to GMP production, non-clinical, and clinical development in the same organization. Our department is part of the Research organization based in Måløv, Denmark and we are experts in cell formulations, cell delivery, cryopreservation, Stem Cell biology, cardiomyocyte biology and assay development (in vitro and ex vivo). We are 20 scientists, technicians and students divided into several teams. The Cell Delivery & Formulation team currently consists of 3 scientists and 2 technicians. We put emphasis on empowerment and a high degree of transparency in all that we do, and offer a dynamic, flexible, and positive working environment with opportunities to develop professionally while solving cutting-edge scientific challenges. We are driven by curiosity and desire to make a difference. Working at Novo Nordisk
At Novo Nordisk, we don’t wait for change. We drive it. We’re a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence without fixating on perfection. We never shy away from opportunities to develop, we
seize them. From research and development, through to manufacturing, marketing and sales – we’re all working to move the needle on patient care. Contact
For further information, please contact Principal Scientist Andrew Adler (available week 28-30) at [email protected] / +45 3448 2813 or Specialist Lars Groth Grunnet (available week 31) at [email protected] / +45 3079 5994. Deadline
7 August 2023 Applications will be reviewed on an ongoing basis. To ensure an efficient and fair recruitment process, please refrain from adding a photo in your CV. We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
We are expanding our team and are looking for two scientists (2-year positions with the possibility to extent) with expertise relevant to the in vitro testing of formulations and the combination of delivery device, formulation, and cells. These tasks cover a multidisciplinary area of cell biology, formulation characterization, microfluidics, biomaterial characterization and in vitro assay development. You will support the progression of our Parkinson’s Disease and Chronic Heart Failure cell therapy programs in Cell Therapy R&D. Your main tasks will include:
• Supporting the team with hands on experiments and in-depth knowledge contributing to the development and maturation of cell formulations enabling the progression of our Parkinson’s Disease and Heart Failure cell therapy programs towards global clinical adoption.
• Being part of our internal and external project teams and responsible for in vitro study designs and execution, assay read-outs, interpretation of results, and communicating and discussing conclusions with a broad spectrum of stakeholders and collaborators across our organization. Qualifications
The position requires curiosity, adaptability, and a creative mindset together with good time and resource management skills. You need to thrive in an environment where we work in collaborative teams and rely on each other; e.g., for technical, strategic, regulatory, and clinical expertise - making communication is an essential skill. To succeed in this role, you have:
• M.Sc. or Ph.D. in engineering, pharmaceutical, biological, biomedical sciences, or a related field. Experience and understanding of in vitro study design,
• hands on-experience in assay development, cell biology and/or biomedical engineering is advantageous.
• Prior knowledge about GLP, GMP, and regulatory frameworks are an advantage but not a prerequisite. About the department
The Department of Cell Delivery & Formulation is a dynamic and diverse department in Cell Therapy R&D, a Transformational Research Unit (TRU) within Novo Nordisk. The TRU is unique in the sense that it covers the full R&D value chain, which means we function as an integrated unit, spanning from early research to GMP production, non-clinical, and clinical development in the same organization. Our department is part of the Research organization based in Måløv, Denmark and we are experts in cell formulations, cell delivery, cryopreservation, Stem Cell biology, cardiomyocyte biology and assay development (in vitro and ex vivo). We are 20 scientists, technicians and students divided into several teams. The Cell Delivery & Formulation team currently consists of 3 scientists and 2 technicians. We put emphasis on empowerment and a high degree of transparency in all that we do, and offer a dynamic, flexible, and positive working environment with opportunities to develop professionally while solving cutting-edge scientific challenges. We are driven by curiosity and desire to make a difference. Working at Novo Nordisk
At Novo Nordisk, we don’t wait for change. We drive it. We’re a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence without fixating on perfection. We never shy away from opportunities to develop, we
seize them. From research and development, through to manufacturing, marketing and sales – we’re all working to move the needle on patient care. Contact
For further information, please contact Principal Scientist Andrew Adler (available week 28-30) at [email protected] / +45 3448 2813 or Specialist Lars Groth Grunnet (available week 31) at [email protected] / +45 3079 5994. Deadline
7 August 2023 Applications will be reviewed on an ongoing basis. To ensure an efficient and fair recruitment process, please refrain from adding a photo in your CV. We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
Information og data
Denne ledige stilling har jobtypen "Forretningsudvikler", og befinder sig i kategorien "Kommunikation, marketing, salg".
Arbejdsstedet er beliggende i Måløv.
Jobbet er oprettet på vores service den 7.7.2023, men kan have været deaktiveret og genaktiveret igen.
Dagligt opdateret: Dette job opdateres dagligt ud fra jobudbyderens hjemmeside via vores søgemaskineteknologi og er aktivt lige nu.
- Forretningsudvikler
- Måløv
Lignende jobs
-
Strategic Trial Planning Manager - Clinical Develo...
Are you ready to drive the successful strategic planning and management of early phase clinical trials, i.e. ClinPharm/Phase 1 studies? Does oversight and cross functional collaboration motivate yo..Få mere info- Forretningsudvikler
- Søborg
-
Senior Scientist in Late-stage Downstream Developm...
Are you ready to shape the future of API process characterization in late-stage downstream development? Do you have the expertise to drive innovative solutions and ensure seamless tech transfer in .Få mere info- Forretningsudvikler
- Bagsværd
-
Global Trial Manager
Are you passionate about clinical development? Is ensuring that clinical trials produce high-quality data and scientific documentation your top priority? If so, we want you to join our team in Card..Få mere info- Forretningsudvikler
- Søborg
-
Udviklingskonsulent til det sociale børne- og unge...
Få mere info- Forretningsudvikler
- Taastrup
Statistik over udbudte jobs som forretningsudviklere i Måløv
Herunder ser du udviklingen i udbudte forretningsudvikler i Måløv over tid. Bemærk at jobs der ikke har en bestemt geografi ikke er medtaget i tabellen. I den første kolonne ser du datoen. I den næste kolonne ser du det samlede antal forretningsudviklere.
Se flere statistikker her:
Statistik over udbudte forretningsudviklere i Måløv over tid
| Dato | Alle jobs som forretningsudviklere |
|---|---|
| 23. november 2024 | 3 |
| 22. november 2024 | 3 |
| 21. november 2024 | 3 |
| 20. november 2024 | 4 |
| 19. november 2024 | 3 |
| 18. november 2024 | 3 |
| 17. november 2024 | 5 |
| 16. november 2024 | 5 |
| 15. november 2024 | 5 |
| 14. november 2024 | 5 |
| 13. november 2024 | 5 |
| 12. november 2024 | 5 |
| 11. november 2024 | 4 |
| 10. november 2024 | 4 |
| 9. november 2024 | 4 |
| 8. november 2024 | 3 |
| 7. november 2024 | 2 |
| 6. november 2024 | 1 |
| 5. november 2024 | 1 |
| 4. november 2024 | 1 |
| 3. november 2024 | 3 |
| 2. november 2024 | 3 |
| 1. november 2024 | 3 |
| 31. oktober 2024 | 4 |
| 30. oktober 2024 | 4 |
| 29. oktober 2024 | 4 |
| 28. oktober 2024 | 4 |
| 27. oktober 2024 | 6 |
| 26. oktober 2024 | 6 |
| 25. oktober 2024 | 7 |
| 24. oktober 2024 | 7 |